유럽 ​​여성 건강 진단 시장 – 2029년까지의 산업 동향 및 예측

TOC 요청 TOC 요청 분석가에게 문의 분석가에게 문의 지금 구매 지금 구매 구매하기 전에 문의 구매하기 전에 문의 무료 샘플 보고서 무료 샘플 보고서

유럽 ​​여성 건강 진단 시장 – 2029년까지의 산업 동향 및 예측

  • Healthcare
  • Upcoming Report
  • May 2022
  • Europe
  • 350 Pages
  • 테이블 수: 220
  • 그림 수: 60

>유럽 ​​여성 건강 진단 시장, 용도별(유방암 검사, 자궁경부암 검사, 임신 및 생식력 검사, 난소암 검사, 감염성 질환 검사, 초음파 검사, 성병 검사 등), 검사(생체검사, 기타 유방암 검사, 임신 및 생식력 검사, 실험실 기반 검사, 임신 검사 및 배란 예측 키트, 생식력 모니터, 산전 유전자 검사 및 보균자 검사, CF 검사, 다운 증후군 및 에드워즈 증후군 검사, TORCH 검사, 기타 산전 유전자 질환 검사, 감염성 질환 검사, MRSA 검사, UTI 검사, 간염 검사) 및 최종 사용자별(진단 및 영상 센터, 병원 및 진료소, 홈 케어) - 업계 동향 및 2029년까지의 예측

유럽 ​​여성 건강 진단 시장

시장 분석 및 규모

세계보건기구에 따르면, 유럽 지역에는 4억 7천만 명 이상의 여성이 살고 있으며, 이는 전체 인구의 절반을 약간 넘는 수치입니다. 고령화와 이주와 같은 이 다양한 지역에서 발생하는 인구 통계적, 역학적 변화를 이해하려면 여성 건강에 대한 이해가 필요합니다. 나아가 세계은행에 따르면, 유럽연합 지역의 2018년 GDP는 약 18조 8,000억 달러였으며, 의료 지출은 사회 보장 지출에 이어 두 번째로 큰 일반 정부 지출 항목입니다. 연방 정부의 총 의료 지출은 GDP의 9.6%였습니다. 이를 통해 유럽의 의료 인프라와 임상 실험실 및 진단 시설의 수가 늘어나 내년에 여성 건강 진단 시장이 활성화될 것입니다.

Data Bridge Market Research는 2021년에 264억 8천만 달러였던 여성 건강 진단 시장이 2029년까지 418억 8천만 달러로 급증할 것으로 분석했으며, 2022-2029년 예측 기간 동안 5.9%의 CAGR을 보일 것으로 예상합니다. Data Bridge Market Research 팀이 큐레이팅한 시장 보고서에는 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크가 포함되어 있습니다.

시장 정의

여성 건강은 여성의 신체적, 정신적 웰빙에 영향을 미칠 수 있는 질병과 질환의 진단 및 치료를 말합니다. 여성 건강에는 피임, 성병(STI), 산부인과 질환, 유방암, 난소암, 기타 여성 암, 폐경, 호르몬 요법, 골다공증, 임신 및 출산, 성 건강, 여성 및 심장병, 여성 생식 기관의 기능에 영향을 미치는 양성 질환이 포함됩니다.

보고 범위 및 시장 세분화

보고서 메트릭

세부

예측 기간

2022년부터 2029년까지

기준 연도

2021

역사적 연도

2020 (2019-2014까지 사용자 정의 가능)

양적 단위

매출은 10억 달러, 볼륨은 단위, 가격은 10억 달러

다루는 세그먼트

신청(유방암 검사, 자궁경부암 검사, 임신 및 생식 능력 검사, 난소암 검사, 감염성 질환 검사, 초음파 검사, 성병 검사 및 기타) 및 최종 사용자(진단 및 영상 센터, 병원 및 진료소, 홈 케어)

적용 국가

북미의 미국, 캐나다 및 멕시코, 유럽의 독일, 프랑스, ​​영국, 네덜란드, 스위스, 벨기에, 러시아, 이탈리아, 스페인, 터키, 기타 유럽

시장 참여자 포함

Siemens(독일), Hologic, Inc.(매사추세츠), Shenzhen Mindray Bio-Medical Electronics Co., Ltd.(중국), Abbott(미국), BD(뉴저지), F. Hoffmann-La Roche Ltd(스위스), Thermo Fisher Scientific Inc.(미국), Koninklijke Philips NV(네덜란드), NeuroLogica Corp.(미국), Shimadzu Medical(인도) pvt. Ltd.(일본), GENERAL ELECTRIC(미국), Quest Diagnostics Incorporated(미국), Sysmex India Pvt. Ltd.(일본), Hitachi, Ltd.(일본), Canon Inc.(일본), FUJIFILM Holdings Corporation(영국)

시장 기회

  •  연구 개발 지출의 증가 추세
  • 소형 진단 장치 개발 증가

여성 건강 진단 시장 동향

운전자

  • 만성질환 및 생활습관 관련 질환의 증가

영상 및 진단 센터의 수가 확대되고, 진료 시점 및 빠른 진단 검사의 사용이 확대되었습니다. 골관절염, 난소암, 유방암, 자궁경부암의 유병률이 증가함에 따라 여성 건강 진단 시장이 성장하고 있습니다. 유방암은 여성에게 가장 흔한 암이며 전 세계에서 두 번째로 흔한 암입니다. 2018년에는 약 200만 건의 신규 사례가 보고되었습니다.

  • 진료 시점 진단 검사 승인율 증가

전 세계적으로 판매되는 진단 및 영상 장비의 수가 증가함에 따라 시장이 성장할 것으로 예상됩니다. 그러나 소형 진단 장비 개발에 대한 수요 급증, 의료 인프라 증가, 신흥국의 주요 공급업체의 새로운 마케팅 이니셔티브는 2022-2029년 예측 기간 동안 시장 확장을 제공할 것으로 예상됩니다.

  • 골관절염, 난소암, 유방암, 자궁경부암의 유병률 증가

 유방암은 여성에게 가장 흔한 암이며 전 세계에서 두 번째로 흔한 암입니다. Globocan 2020에 따르면 2020년에 2,261,419건의 새로운 유방암 사례가 진단될 것으로 예상됩니다. 증가하는 사례 수로 인해 가정용 검사 키트 판매가 증가했으며, 이는 예측 기간 내내 시장 매출 성장을 촉진할 것으로 예상됩니다. 진료소 진단 검사의 수용 증가와 전 세계적으로 사용 가능한 진단 및 영상 장비의 수가 증가함에 따라 시장이 앞으로 나아갈 것으로 예상됩니다.

기회

Breast cancer's rising prevalence, greater research and development spending, and improvements in cancer diagnostics are all expected to accelerate segmental expansion. According to Globocan, roughly 2.26 million new instances of breast cancer were diagnosed in females worldwide in 2020, accounting for around 11.7 percent of all cancer cases. As the patient pool for breast cancer develops, demand for diagnostics is projected to climb even quicker. Product launches are another major factor in the market's expansion.

Restraints/Challenges

Patients' resistance to early screening, which needs considerable expenditures for detection, the possibility of over-diagnosis and overtreatment, and the fact that MRI scans are accurate yet time consuming and costly for patients are all problems that the women's health diagnostic market faces.

Diagnostic tests for women's health are costly, which is a significant barrier to market entry. The women's health diagnostic sector has considerable challenges due to a lack of information about various illnesses and diagnostic methodologies. Low-income companies and emerging economies are addressing market constraints in women's health diagnostics.

This  women’s health diagnostics  market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the women’s health diagnostics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Women’s Health Diagnostics Market

Due to capital market and global economy uncertainty, limited transit options and travel restrictions created impediments to international trade and transportation during the COVID-19 pandemic, affecting the supply chain for women's health diagnostics and temporarily lowering demand. The advancement of this industry is impeded by unfavourable changes in rules and laws. According to major regulatory organisations, COVID-19 infection is more common in breast cancer patients than in healthy people. Screening, surgical operations, and diagnostic screenings at hospitals and breast cancer clinics have all been postponed or severely curtailed as a result.

Recent Development

  • Roche announced in May 2019 that the VENTANA HER2 Dual ISH DNA Probe Cocktail assay for detecting the HER2 biomarker in gastric and breast cancer would be available. This would contribute to the company's product line being expanded.

Europe Women’s Health Diagnostics Market Scope

The women’s health diagnostics market is segmented on the basis of test, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Application

  • Osteoporosis Testing
  • Bone Densitometry
  • In Vitro Blood Tests
  • OVC Testing
  • OVC Tumor Marker Tests
  • OVC Diagnostic Imaging Tests
  • Other OVC Tests
  • Cervical Cancer Testing
  • Pap Smears
  • HPV Testing
  • Breast Cancer Testing
  • Mammography

Tests

  • Biopsies
  • Other Breast Cancer Tests
  • Pregnancy and Fertility Testing
  • Lab-based Testing
  • Pregnancy Testing and Ovulation Prediction Kits
  • Fertility Monitors
  • Prenatal Genetic Screening and Carrier Testing
  • CF Testing
  • Down’s Syndrome and Edwards’ Syndrome Testing
  • TORCH Testing
  • Other Prenatal Genetic Disease Tests
  • Infectious Disease Testing
  • MRSA Testing
  • UTI Testing
  • Hepatitis Testing
    • Tuberculosis Testing
    • Other Infectious Disease Tests
    • STD Testing
    • CT/NG Testing
    • HIV Testing
    • Other STD Tests
    • Ultrasound Tests
    • Breast Imaging
    • OB/GYN Imaging

End-User

  • Hospitals and Clinics
  • Diagnostic and Imaging Centers
  • Home Care Settings

 Women’s Health Diagnostics Market Regional Analysis/Insights

The women’s health diagnostics market is analysed and market size insights and trends are provided by country, test, application and end user as referenced above.

The countries covered in the  women’s health diagnostics  market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

The high prevalence of cancer among women, the rising incidence of lifestyle-related disorders, the high adoption of technologically advanced products, product launches, and government initiatives, the women's health diagnostic market in North America and Europe is expected to grow steadily.

By increasing campaigns on women's health issues and disease awareness, the Asia-Pacific region has improved its healthcare situation and has emerged as a growing participant in the women's health diagnostic market.

보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 다운스트림 및 업스트림 가치 사슬 분석, 기술 트렌드 및 포터의 5가지 힘 분석, 사례 연구와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 몇 가지 포인터입니다. 또한 글로벌 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 국내 관세 및 무역 경로의 영향은 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.   

의료 인프라 성장 설치 기반 및 신기술 침투

여성 건강 진단 시장은 또한 모든 국가에 대한 자세한 시장 분석, 자본 장비에 대한 의료 지출 증가, 여성 건강 진단 시장을 위한 다양한 종류의 제품 설치 기반, 라이프라인 곡선을 사용한 기술의 영향, 의료 규제 시나리오의 변화 및 여성 건강 진단 시장에 미치는 영향을 제공합니다. 이 데이터는 2010-2020년의 과거 기간에 대해 제공됩니다.

경쟁 환경 및 여성 건강 진단 시장 점유율 분석

여성 건강 진단 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우세입니다. 위에 제공된 데이터 포인트는 여성 건강 진단 시장과 관련된 회사의 초점에만 관련이 있습니다.

여성 건강 진단 시장에서 활동하는 주요 기업은 다음과 같습니다.

  • 지멘스(독일)
  • 홀로직 주식회사 (MA)
  • 심천 Mindray Bio-Medical Electronics Co., Ltd. (중국)
  • 애벗(미국)
  • BD(뉴저지)
  • F. 호프만-라 로슈 유한회사(스위스)
  • Thermo Fisher Scientific Inc. (미국)
  • Koninklijke Philips NV(네덜란드)
  • NeuroLogica Corp.(미국)
  • Shimadzu Medical (India) pvt. Ltd. (일본)
  • 제너럴 일렉트릭(미국)
  • Quest Diagnostics Incorporated(미국)
  • Sysmex India Pvt. Ltd.(일본)
  • 히타치 주식회사(일본)
  • 캐논 주식회사(일본)
  • 후지필름 홀딩스 코퍼레이션(영국)


SKU-

세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요

  • 대화형 데이터 분석 대시보드
  • 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
  • 사용자 정의 및 질의를 위한 리서치 분석가 액세스
  • 대화형 대시보드를 통한 경쟁자 분석
  • 최신 뉴스, 업데이트 및 추세 분석
  • 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
데모 요청

목차

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.7 DBMR VENDOR SHARE ANALYSIS

2.8 MULTIVARIATE MODELING

2.9 PRODUCTS LIFELINE CURVE

2.1 SECONDARY SOURCES

2.11 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS

3.1.1 INCREASING GERIATRIC FEMALE POPULATION

3.1.2 INCREASING NUMBER OF INFECTIOUS AND CHRONIC DISEASES

3.1.3 INCREASING INVESTMENTS IN THE RESEARCH AND DEVELOPMENTAL ACTIVITIES

3.1.4 GROWING NUMBER OF DIAGNOSTIC DEVICE MANUFACTURING COMPANIES

3.2 RESTRAINTS

3.2.1 PRODUCT RECALLS OF VARIOUS COMPANIES

3.2.2 HIGH COST OF DIAGNOSTIC PRODUCTS

3.3 OPPORTUNITIES

3.3.1 TECHNOLOGICAL ADVANCEMENTS IN THE DIAGNOSTIC EQUIPMENT

3.3.2 STRATEGIC INITIATIVES BY VARIOUS COMPANIES

3.4 CHALLENGES

3.4.1 UNACCEPTABLE HEALTH DISPARITIES IN THE U.S.

3.4.2 PRICING PRESSURE

3.4.3 INCREASING ADOPTION OF REFURBISHED DIAGNOSTIC IMAGING SYSTEMS

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES

6.1 OVERVIEW

6.2 IMAGING AND MONITORING SYSTEMS

6.2.1 MAMMOGRAPHY SYSTEMS

6.2.1.1 DEVICES

6.2.1.1.1 DIGITAL MAMMOGRAPHY SYSTEMS

6.2.1.1.2 BREAST TOMOSYNTHESIS

6.2.1.1.3 ANALOG MAMMOGRAPHY SYSTEMS

6.2.1.2 APPLICATIONS

6.2.1.2.1 BREAST LUMPS OR TUMORS

6.2.1.2.2 BREAST CANCER

6.2.1.2.3 OTHERS

6.2.2 ULTRASOUND IMAGING SYSTEMS

6.2.2.1 DEVICES

6.2.2.1.1 OB/GYN ULTRASOUND

6.2.2.1.2 BREAST ULTRASOUND

6.2.2.2 APPLICATIONS

6.2.2.2.1 PREGNANCY SCAN

6.2.2.2.1.1 FETAL DEVELOPMENT

6.2.2.2.1.2 FETAL ABNORMALITIES

6.2.2.2.1.3 OTHERS

6.2.2.2.2 PELVIC SCAN

6.2.2.2.2.1 ABNORMAL PERIODS

6.2.2.2.2.2 CYSTS

6.2.2.2.2.3 FIBROIDS

6.2.2.2.2.4 OTHERS

6.2.2.2.3 ABDOMINAL SCAN

6.2.2.2.4 OTHERS

6.2.2.2.4.1 BREAST SCANS

6.2.2.2.4.2 MUSCULOSKELETAL SCANS

6.2.2.2.4.3 INTERNAL STRUCTURES

6.2.3 MRI SYSTEMS

6.2.3.1 APPLICATIONS

6.2.3.1.1 BREAST SCAN

6.2.3.1.2 ABDOMEN SCAN

6.2.3.1.3 JOINTS SCAN

6.2.3.1.4 SPINAL CORD SCAN

6.2.3.1.5 CARDIAC SCAN

6.2.3.1.6 BLOOD VESSELS SCAN

6.2.3.1.7 OTHERS

6.2.4 FERTILITY MONITORS

6.2.4.1 APPLICATIONS

6.2.4.1.1 OVULATION

6.2.4.1.2 INFERTILITY

6.2.4.1.3 PREGNANCY

6.2.4.1.4 HORMONAL IMBALANCE

6.2.4.1.5 OTHERS

6.2.5 BONE DENSITOMETER

6.2.5.1 APPLICATIONS

6.2.5.1.1 OSTEOPOROSIS

6.2.5.1.2 BONE-RELATED PROBLEMS

6.2.5.1.3 RHEUMATOID ARTHRITIS

6.2.6 NUCLEAR IMAGING SYSTEMS

6.2.6.1 APPLICATIONS

6.2.6.1.1 OSTEOARTHRITIS

6.2.6.1.2 HEART DISEASE

6.2.6.1.3 UROLOGICAL PROBLEMS

6.2.6.1.4 GYNECOLOGICAL CANCERS

6.2.6.1.5 MULTIPLE SCLEROSIS

6.2.6.1.6 ALZHEIMER’S DISEASE

6.2.6.1.7 THYROID DISEASE

6.2.6.1.8 SEXUALLY TRANSMITTED INFECTIONS

6.2.6.1.9 STROKE

6.2.6.1.10 POST-TRAUMATIC STRESS DISORDER (PTSD)

6.2.6.1.11 LUPUS

6.2.6.1.12 OTHERS

6.2.7 OTHERS

6.3 BIOPSY DEVICES

6.3.1 BIOPSY FOR CANCER

6.3.1.1 BREAST CANCER

6.3.1.2 CERVICAL CANCER

6.3.1.3 OVARIAN CANCER

6.3.1.4 OTHERS

6.3.2 BREAST LUMPS BIOPSY

6.3.3 BLOOD BIOPSY

6.3.3.1 CANCEROUS

6.3.3.2 NON-CANCEROUS

6.3.4 LYMPH NODES BIOPSY

6.3.5 THYROID BIOPSY

6.3.6 SKIN BIOPSY

6.3.7 OTHERS

6.4 REAGENTS AND KITS

6.4.1 PREGNANCY AND FERTILITY TESTING KITS

6.4.1.1 PREGNANCY

6.4.1.2 OVULATION

6.4.1.3 OTHERS

6.4.2 BLOOD TEST TYPE KIT

6.4.2.1 OSTEOPOROSIS

6.4.2.2 BLOOD CHEMISTRY & BLOOD CELL COUNT

6.4.2.3 OTHERS

6.4.3 HEPATITIS TESTING KIT

6.4.4 TUMOR MARKER ELISA TEST KIT

6.4.5 STD TEST KITS

6.4.5.1 HIV TESTING

6.4.5.2 HUMAN PAPILLOMAVIRUS (HPV) TESTING

6.4.5.3 CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE (CT/NG) TESTING

6.4.5.4 OTHERS

6.4.6 PAP SMEAR TEST KIT

6.4.7 MRSA TESTING KITS

6.4.8 HORMONE MARKERS ELISA KITS

6.4.9 TUBERCULOSIS TEST KIT

6.4.10 OTHERS

6.5 BIOMARKERS

6.5.1 ONCOLOGY

6.5.1.1 BREAST CANCER

6.5.1.2 CERVICAL CANCER

6.5.1.3 OVARIAN CANCER

6.5.1.4 OTHERS

6.5.2 PREGNANCY COMPLICATIONS

6.5.3 INFECTIOUS DISEASES

6.5.4 CARDIOVASCULAR DISEASES

6.5.5 OTHERS

6.6 OTHERS

7 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET, BY END USER

7.1 OVERVIEW

7.2 HOSPITALS

7.3 DIAGNOSTIC AND IMAGING CENTERS

7.4 CLINICS

7.5 HOME CARE SETTING

8 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET, BY GEOGRAPHY

8.1 EUROPE

8.1.1 GERMANY

8.1.2 FRANCE

8.1.3 U.K.

8.1.4 ITALY

8.1.5 SPAIN

8.1.6 RUSSIA

8.1.7 SWITZERLAND

8.1.8 NETHERLANDS

8.1.9 BELGIUM

8.1.10 TURKEY

8.1.11 REST OF EUROPE

9 EUROPE BIOPSY DEVICES IN WOMEN’S HEALTH DIAGNOSTICS MARKET, COMPANY LANDSCAPE

9.1 COMPANY SHARE ANALYSIS: EUROPE

10 EUROPE MAMMOGRAPHY SYSTEM IN WOMEN’S HEALTH DIAGNOSTICS MARKET, COMPANY LANDSCAPE

10.1 COMPANY SHARE ANALYSIS: EUROPE

11 EUROPE ULTRASONIC IMAGING SYSTEM IN WOMEN’S HEALTH DIAGNOSTICS MARKET, COMPANY LANDSCAPE

11.1 COMPANY SHARE ANALYSIS: EUROPE

12 EUROPE MRI SYSTEM IN WOMEN’S HEALTH DIAGNOSTICS MARKET, COMPANY LANDSCAPE

12.1 COMPANY SHARE ANALYSIS: EUROPE

13 COMPANY PROFILE

13.1 HOLOGIC INC

13.1.1 COMPANY SNAPSHOT

13.1.2 REVENUE ANALYSIS

13.1.3 COMPANY SHARE ANALYSIS

13.1.4 PRODUCT PORTFOLIO

13.1.5 RECENT DEVELOPMENTS

13.2 SIEMENS

13.2.1 COMPANY SNAPSHOT

13.2.2 REVENUE ANALYSIS

13.2.3 COMPANY SHARE ANALYSIS

13.2.4 PRODUCT PORTFOLIO

13.2.5 RECENT DEVELOPMENTS

13.3 GENERAL ELECTRIC

13.3.1 COMPANY SNAPSHOT

13.3.2 REVENUE ANALYSIS

13.3.3 COMPANY SHARE ANALYSIS

13.3.4 PRODUCT PORTFOLIO

13.3.5 RECENT DEVELOPMENT

13.4 KONINKLIJKE PHILIPS N.V.

13.4.1 COMPANY SNAPSHOT

13.4.2 REVENUE ANALYSIS

13.4.3 COMPANY SHARE ANALYSIS

13.4.4 PRODUCT PORTFOLIO

13.4.5 RECENT DEVELOPMENTS

13.5 HITACHI, LTD.

13.5.1 COMPANY SNAPSHOT

13.5.2 REVENUE ANALYSIS

13.5.3 COMPANY SHARE ANALYSIS

13.5.4 PRODUCT PORTFOLIO

13.5.5 RECENT DEVELOPMENTS

13.6 FUJIFILM HOLDINGS CORPORATION

13.6.1 COMPANY SNAPSHOT

13.6.2 REVENUE ANALYSIS

13.6.3 COMPANY SHARE ANALYSIS

13.6.4 PRODUCT PORTFOLIO

13.6.5 RECENT DEVELOPMENTS

13.7 ABBOTT

13.7.1 COMPANY SNAPSHOT

13.7.2 REVENUE ANALYSIS

13.7.3 PRODUCT PORTFOLIO

13.7.4 RECENT DEVELOPMENTS

13.8 BD

13.8.1 COMPANY SNAPSHOT

13.8.2 REVENUE ANALYSIS

13.8.3 PRODUCT PORTFOLIO

13.8.4 RECENT DEVELOPMENTS

13.9 BIOMERIEUX SA

13.9.1 COMPANY SNAPSHOT

13.9.2 REVENUE ANALYSIS

13.9.3 PRODUCT PORTFOLIO

13.9.4 RECENT DEVELOPMENT

13.1 BIOMERIEUX SA

13.10.1 COMPANY SNAPSHOT

13.10.2 REVENUE ANALYSIS

13.10.3 PRODUCT PORTFOLIO

13.10.4 RECENT DEVELOPMENT

13.11 CANON INC.

13.11.1 COMPANY SNAPSHOT

13.11.2 REVENUE ANALYSIS

13.11.3 PRODUCT PORTFOLIO

13.11.4 RECENT DEVELOPMENTS

13.12 CARDINAL HEALTH

13.12.1 COMPANY SNAPSHOT

13.12.2 REVENUE ANALYSIS

13.12.3 PRODUCT PORTFOLIO

13.12.4 RECENT DEVELOPMENT

13.13 CARESTREAM HEALTH

13.13.1 COMPANY SNAPSHOT

13.13.2 PRODUCT PORTFOLIO

13.13.3 RECENT DEVELOPMENT

13.14 COOK

13.14.1 COMPANY SNAPSHOT

13.14.2 DIVISION PORTFOLIO

13.14.3 RECENT DEVELOPMENTS

13.15 DANAHER

13.15.1 COMPANY SNAPSHOT

13.15.2 REVENUE ANALYSIS

13.15.3 PRODUCT PORTFOLIO

13.15.4 RECENT DEVELOPMENTS

13.16 F. HOFFMANN-LA ROCHE LTD.

13.16.1 COMPANY SNAPSHOT

13.16.2 REVENUE ANALYSIS

13.16.3 PRODUCT PORTFOLIO

13.16.4 RECENT DEVELOPMENTS

13.17 MEDGYN PRODUCTS, INC

13.17.1 COMPANY SNAPSHOT

13.17.2 PRODUCT PORTFOLIO

13.17.3 RECENT DEVELOPMENT

13.18 NEUROLOGICA CORP.

13.18.1 COMPANY SNAPSHOT

13.18.2 PRODUCT PORTFOLIO

13.18.3 RECENT DEVELOPMENTS

13.19 PERKINELMER INC.

13.19.1 COMPANY SNAPSHOT

13.19.2 REVENUE ANALYSIS

13.19.3 PRODUCT PORTFOLIO

13.19.4 RECENT DEVELOPMENT

13.2 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.

13.20.1 COMPANY SNAPSHOT

13.20.2 PRODUCT PORTFOLIO

13.20.3 RECENT DEVELOPMENTS

13.21 SHIMADZU CORPORATION

13.21.1 COMPANY SNAPSHOT

13.21.2 REVENUE ANALYSIS

13.21.3 PRODUCT PORTFOLIO

13.21.4 RECENT DEVELOPEMNT

13.22 SYSMEX CORPORATION

13.22.1 COMPANY SNAPSHOT

13.22.2 REVENUE ANALYSIS

13.22.3 PRODUCT PORTFOLIO

13.22.4 RECENT DEVELOPMENT

13.23 THERMO FISHER SCIENTIFIC INC.

13.23.1 COMPANY SNAPSHOT

13.23.2 REVENUE ANALYSIS

13.23.3 PRODUCT PORTFOLIO

13.23.4 RECENT DEVELOPMENTS

13.24 URIT MEDICAL ELECTRONIC CO., LTD

13.24.1 COMPANY SNAPSHOT

13.24.2 PRODUCT PORTFOLIO

13.24.3 RECENT DEVELOPMENT

14 CONCLUSION

15 SWOT ANALYSIS AND DBMR ANALYSIS

15.1 SWOT ANALYSIS

15.2 DATA BRIDGE MARKET RESEARCH ANALYSIS

16 QUESTIONNAIRE

17 RELATED REPORTS

표 목록

TABLE 1 RESEARCH AND DEVELOPMENT (USD MILLION)

TABLE 2 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 3 EUROPE IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 4 EUROPE IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 5 EUROPE MAMMOGRAPHY SYSTEMS DEVICES IN WOMEN’S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICE, 2017-2026 (USD MILLION)

TABLE 6 EUROPE APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICE , 2017-2026 (USD MILLION)

TABLE 7 EUROPE ULTRASOUND IMAGING SYSTEMS DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICE , 2017-2026 (USD MILLION)

TABLE 8 EUROPE APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICE , 2017-2026 (USD MILLION)

TABLE 9 EUROPE PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY APPLICATIONS, 2017-2026 (USD MILLION)

TABLE 10 EUROPE PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY APPLICATIONS, 2017-2026 (USD MILLION)

TABLE 11 EUROPE OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY APPLICATIONS, 2017-2026 (USD MILLION)

TABLE 12 EUROPE APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICES, 2017-2026 (USD MILLION)

TABLE 13 EUROPE APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICES , 2017-2026 (USD MILLION)

TABLE 14 EUROPE BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICES, 2017-2026 (USD MILLION)

TABLE 15 EUROPE APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICES , 2017-2026 (USD MILLION)

TABLE 16 EUROPE BIOPSY DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 17 EUROPE BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICES, 2017-2026 (USD MILLION)

TABLE 18 EUROPE BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICES , 2017-2026 (USD MILLION)

TABLE 19 EUROPE BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICES, 2017-2026 (USD MILLION)

TABLE 20 EUROPE REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 21 EUROPE REAGENTS AND KITS IN WOMEN’S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 22 EUROPE PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 23 EUROPE BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 24 EUROPE STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 25 EUROPE BIOMARKERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 26 EUROPE BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICES, 2017-2026 (USD MILLION)

TABLE 27 EUROPE ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTICS DEVICES , 2017-2026 (USD MILLION)

TABLE 28 EUROPE OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 29 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 30 EUROPE HOSPITALS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 31 EUROPE DIAGNOSTIC AND IMAGING CENTERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 32 EUROPE CLINICS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 33 EUROPE HOME CARE SETTING IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 34 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET, BY COUNTRY, 2017-2026 (USD MILLION)

TABLE 35 EUROPE WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 36 EUROPE IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 37 EUROPE MAMMOGRAPHY SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 38 EUROPE APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 39 EUROPE ULTRASOUND IMAGING SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 40 EUROPE APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 41 EUROPE PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 42 EUROPE PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 43 EUROPE OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 44 EUROPE APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 45 EUROPE APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 46 EUROPE APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 47 EUROPE BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 48 EUROPE BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 49 EUROPE BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 50 EUROPE BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 51 EUROPE BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 52 EUROPE ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 53 EUROPE REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 54 EUROPE PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 55 EUROPE BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 56 EUROPE STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 57 EUROPE WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 58 GERMANY WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 59 GERMANY IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 60 GERMANY MAMMOGRAPHY SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 61 GERMANY APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 62 GERMANY ULTRASOUND IMAGING SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 63 GERMANY APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 64 GERMANY PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 65 GERMANY PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 66 GERMANY OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 67 GERMANY APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 68 GERMANY APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 69 GERMANY APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 70 GERMANY BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 71 GERMANY BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 72 GERMANY BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 73 GERMANY BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 74 GERMANY BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 75 GERMANY ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 76 GERMANY REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 77 GERMANY PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 78 GERMANY BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 79 GERMANY STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 80 GERMANY WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 81 FRANCE WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 82 FRANCE IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 83 FRANCE MAMMOGRAPHY SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 84 FRANCE APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 85 FRANCE ULTRASOUND IMAGING SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 86 FRANCE APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 87 FRANCE PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 88 FRANCE PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 89 FRANCE OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 90 FRANCE APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 91 FRANCE APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 92 FRANCE APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 93 FRANCE BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 94 FRANCE BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 95 FRANCE BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 96 FRANCE BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 97 FRANCE BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 98 FRANCE ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 99 FRANCE REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 100 FRANCE PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 101 FRANCE BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 102 FRANCE STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 103 FRANCE WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 104 U.K. WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 105 U.K. IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 106 U.K. MAMMOGRAPHY SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 107 U.K. APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 108 U.K. ULTRASOUND IMAGING SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 109 U.K. APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 110 U.K. PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 111 U.K. PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 112 U.K. OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 113 U.K. APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 114 U.K. APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 115 U.K. APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 116 U.K. BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 117 U.K. BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 118 U.K. BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 119 U.K. BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 120 U.K. BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 121 U.K. ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 122 U.K. REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 123 U.K. PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 124 U.K. BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 125 U.K. STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 126 U.K. WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 127 ITALY WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 128 ITALY IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 129 ITALY MAMMOGRAPHY SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 130 ITALY APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 131 ITALY ULTRASOUND IMAGING SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 132 ITALY APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 133 ITALY PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 134 ITALY PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 135 ITALY OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 136 ITALY APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 137 ITALY APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 138 ITALY APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 139 ITALY BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 140 ITALY BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 141 ITALY BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 142 ITALY BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 143 ITALY BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 144 ITALY ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 145 ITALY REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 146 ITALY PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 147 ITALY BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 148 ITALY STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 149 ITALY WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 150 SPAIN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 151 SPAIN IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 152 SPAIN MAMMOGRAPHY SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 153 SPAIN APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 154 SPAIN ULTRASOUND IMAGING SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 155 SPAIN APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 156 SPAIN PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 157 SPAIN PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 158 SPAIN OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 159 SPAIN APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 160 SPAIN APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 161 SPAIN APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 162 SPAIN BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 163 SPAIN BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 164 SPAIN BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 165 SPAIN BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 166 SPAIN BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 167 SPAIN ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 168 SPAIN REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 169 SPAIN PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 170 SPAIN BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 171 SPAIN STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 172 SPAIN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 173 RUSSIA WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 174 RUSSIA IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 175 RUSSIA MAMMOGRAPHY SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 176 RUSSIA APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 177 RUSSIA ULTRASOUND IMAGING SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 178 RUSSIA APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 179 RUSSIA PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 180 RUSSIA PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 181 RUSSIA OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 182 RUSSIA APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 183 RUSSIA APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 184 RUSSIA APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 185 RUSSIA BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 186 RUSSIA BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 187 RUSSIA BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 188 RUSSIA BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 189 RUSSIA BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 190 RUSSIA ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 191 RUSSIA REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 192 RUSSIA PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 193 RUSSIA BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 194 RUSSIA STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 195 RUSSIA WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 196 SWITZERLAND WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 197 SWITZERLAND IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 198 SWITZERLAND MAMMOGRAPHY SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 199 SWITZERLAND APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 200 SWITZERLAND ULTRASOUND IMAGING SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 201 SWITZERLAND APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 202 SWITZERLAND PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 203 SWITZERLAND PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 204 SWITZERLAND OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 205 SWITZERLAND APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 206 SWITZERLAND APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 207 SWITZERLAND APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 208 SWITZERLAND BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 209 SWITZERLAND BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 210 SWITZERLAND BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 211 SWITZERLAND BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 212 SWITZERLAND BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 213 SWITZERLAND ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 214 SWITZERLAND REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 215 SWITZERLAND PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 216 SWITZERLAND BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 217 SWITZERLAND STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 218 SWITZERLAND WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 219 NETHERLANDS WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 220 NETHERLANDS IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 221 NETHERLANDS MAMMOGRAPHY SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 222 NETHERLANDS APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 223 NETHERLANDS ULTRASOUND IMAGING SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 224 NETHERLANDS APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 225 NETHERLANDS PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 226 NETHERLANDS PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 227 NETHERLANDS OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 228 NETHERLANDS APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 229 NETHERLANDS APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 230 NETHERLANDS APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 231 NETHERLANDS BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 232 NETHERLANDS BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 233 NETHERLANDS BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 234 NETHERLANDS BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 235 NETHERLANDS BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 236 NETHERLANDS ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 237 NETHERLANDS REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 238 NETHERLANDS PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 239 NETHERLANDS BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 240 NETHERLANDS STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 241 NETHERLANDS WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 242 BELGIUM WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 243 BELGIUM IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 244 BELGIUM MAMMOGRAPHY SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 245 BELGIUM APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 246 BELGIUM ULTRASOUND IMAGING SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 247 BELGIUM APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 248 BELGIUM PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 249 BELGIUM PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 250 BELGIUM OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 251 BELGIUM APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 252 BELGIUM APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 253 BELGIUM APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 254 BELGIUM BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 255 BELGIUM BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 256 BELGIUM BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 257 BELGIUM BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 258 BELGIUM BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 259 BELGIUM ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 260 BELGIUM REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 261 BELGIUM PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 262 BELGIUM BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 263 BELGIUM STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 264 BELGIUM WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION

TABLE 265 TURKEY WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 266 TURKEY IMAGING AND MONITORING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 267 TURKEY MAMMOGRAPHY SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 268 TURKEY APPLICATIONS OF MAMMOGRAPHY SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 269 TURKEY ULTRASOUND IMAGING SYSTEMS - DEVICES IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 270 TURKEY APPLICATIONS OF ULTRASOUND IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 271 TURKEY PREGNANCY SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 272 TURKEY PELVIC SCAN IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 273 TURKEY OTHERS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 274 TURKEY APPLICATIONS OF NUCLEAR IMAGING SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 275 TURKEY APPLICATIONS OF MRI SYSTEMS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 276 TURKEY APPLICATIONS OF FERTILITY MONITORS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 277 TURKEY BONE DENSITOMETER APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 278 TURKEY BIOPSY DEVICES APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 279 TURKEY BLOOD BIOPSY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 280 TURKEY BIOPSY FOR CANCER IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 281 TURKEY BIOMARKERS APPLICATIONS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)\

TABLE 282 TURKEY ONCOLOGY IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 283 TURKEY REAGENTS AND KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 284 TURKEY PREGNANCY AND FERTILITY TESTING KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 285 TURKEY BLOOD TEST TYPE KIT IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 286 TURKEY STD TEST KITS IN WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

TABLE 287 TURKEY WOMEN'S HEALTH DIAGNOSTICS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 288 REST OF EUROPE WOMEN'S HEALTH DIAGNOSTICS MARKET, BY DIAGNOSTIC DEVICES, 2017-2026 (USD MILLION)

그림 목록

FIGURE 1 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: SEGMENTATION

FIGURE 2 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: DATA VALIDATION MODEL

FIGURE 3 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: DROC ANALYSIS

FIGURE 4 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: EUROPE VS REGIONAL ANALYSIS

FIGURE 5 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 EUROPE BIOPSY DEVICES IN WOMEN’S HEALTH DIAGNOSTICS MARKET: DBMR VENDOR SHARE ANALYSIS

FIGURE 8 EUROPE MAMMOGRAPHY SYSTEM IN WOMEN’S HEALTH DIAGNOSTICS MARKET: DBMR VENDOR SHARE ANALYSIS

FIGURE 9 EUROPE ULTRASONIC IMAGING SYSTEM IN WOMEN’S HEALTH DIAGNOSTICS MARKET: DBMR VENDOR SHARE ANALYSIS

FIGURE 10 EUROPE MRI SYSTEM IN WOMEN’S HEALTH DIAGNOSTICS MARKET: DBMR VENDOR SHARE ANALYSIS

FIGURE 11 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGE OF EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET

FIGURE 12 PERCENT DISTRIBUTION OF THE 10 LEADING CAUSES OF DEATH IN WOMEN: UNITED STATES, 2017

FIGURE 13 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: SEGMENTATION

FIGURE 14 INCREASING NUMBER OF INFECTIOUS AND CHRONIC DISEASES AND INCREASING INVESTMENTS IN THE RESEARCH AND DEVELOPMENTAL ACTIVITIES ARE EXPECTED TO DRIVE THE EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET IN THE FORECAST PERIOD OF 2019 TO 2026

FIGURE 15 IMAGING AND MONTORING IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET IN THE FORECAST PERIOD OF 2019 TO 2026

FIGURE 16 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: BY DIAGNOSTIC DEVICES, 2018

FIGURE 17 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: BY END USER, 2018

FIGURE 18 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: SNAPSHOT (2018)

FIGURE 19 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: BY COUNTRY (2018)

FIGURE 20 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: BY COUNTRY (2019 & 2026)

FIGURE 21 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: BY COUNTRY (2018 & 2026)

FIGURE 22 EUROPE WOMEN’S HEALTH DIAGNOSTICS MARKET: BY DIAGNOSTIC DEVICES (2019-2026)

FIGURE 23 EUROPE BIOPSY DEVISE IN WOMEN’S HEALTH DIAGNOSTICS MARKET: COMPANY SHARE 2018 (%)

FIGURE 24 EUROPE MAMMOGRAPHY SYSTEM IN WOMEN’S HEALTH DIAGNOSTICS MARKET: COMPANY SHARE 2018 (%)

FIGURE 25 EUROPE ULTRASONIC IMAGING SYSTEM IN WOMEN’S HEALTH DIAGNOSTICS MARKET: COMPANY SHARE 2018 (%)

FIGURE 26 EUROPE MRI SYSTEM IN WOMEN’S HEALTH DIAGNOSTICS MARKET: COMPANY SHARE 2018 (%)

자세한 정보 보기 Right Arrow

연구 방법론

데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.

DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.

사용자 정의 가능

Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.

자주 묻는 질문

The Europe Women’s Health Diagnostics Market value is expected USD 41.88 billion by 2029.
The Europe Women’s Health Diagnostics Market is projected to grow at a CAGR of 5.9% during the forecast period of 2022-2029.
On the basis of application, the Europe Women’s Health Diagnostics Market is segmented into (Breast Cancer Testing, Cervical Cancer Testing, Pregnancy and Fertility Testing, Ovarian Cancer Testing, Infectious Disease Testing, Ultrasound Tests, Sexually Transmitted Disease Testing, and Others.
The major players operating in the Europe Women’s Health Diagnostics Market are Siemens (Germany), Hologic, Inc. (MA), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Abbott (U.S.), BD (NJ), F. Hoffmann-La Roche Ltd (Switzerland), Thermo Fisher Scientific Inc. (U.S.), Koninklijke Philips N.V. (Netherlands), NeuroLogica Corp.(U.S.A), Shimadzu Medical (India) pvt. Ltd. (Japan), GENERAL ELECTRIC (U.S.), Quest Diagnostics Incorporated (U.S.), Sysmex India Pvt. Ltd. (Japan), Hitachi, Ltd. (Japan), Canon Inc. (Japan), FUJIFILM Holdings Corporation (U.K).